Home/Filings/4/0001144204-17-045450
4//SEC Filing

Maveron General Partner III LLC 4

Accession 0001144204-17-045450

CIK 0001371285other

Filed

Aug 27, 8:00 PM ET

Accepted

Aug 28, 7:46 PM ET

Size

26.5 KB

Accession

0001144204-17-045450

Insider Transaction Report

Form 4
Period: 2017-08-24
Transactions
  • Other

    Common Stock

    2017-08-24847,7873,012,685 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24116,243413,080 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24+8,4788,478 total
  • Other

    Common Stock

    2017-08-24+3608,838 total
  • Other

    Common Stock

    2017-08-248,8380 total
  • Other

    Common Stock

    2017-08-2435,970127,821 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24+1,0332,688 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2017-08-2435,970127,821 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24+1,0332,688 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-248,8380 total
  • Other

    Common Stock

    2017-08-24116,243413,080 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24847,7873,012,685 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24+8,4788,478 total
  • Other

    Common Stock

    2017-08-24+3608,838 total
Transactions
  • Other

    Common Stock

    2017-08-24116,243413,080 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24+3608,838 total
  • Other

    Common Stock

    2017-08-24+8,4788,478 total
  • Other

    Common Stock

    2017-08-248,8380 total
  • Other

    Common Stock

    2017-08-24847,7873,012,685 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-2435,970127,821 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24+1,0332,688 total(indirect: See footnote)
Transactions
  • Other

    Common Stock

    2017-08-24116,243413,080 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-2435,970127,821 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24+1,0332,688 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24+8,4788,478 total
  • Other

    Common Stock

    2017-08-248,8380 total
  • Other

    Common Stock

    2017-08-24847,7873,012,685 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24+3608,838 total
Maveron LLC
10% Owner
Transactions
  • Other

    Common Stock

    2017-08-24+3608,838 total
  • Other

    Common Stock

    2017-08-24+1,0332,688 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24847,7873,012,685 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-24116,243413,080 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-2435,970127,821 total(indirect: See footnote)
  • Other

    Common Stock

    2017-08-248,8380 total
  • Other

    Common Stock

    2017-08-24+8,4788,478 total
Footnotes (11)
  • [F1]Maveron Equity Partners III, L.P. ("Maveron Equity") made pro rata distributions for no consideration of 847,787 shares of common stock of the issuer to its partners on August 24, 2017.
  • [F10]Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron Associates and to the members of Maveron GP.
  • [F11]Shares are owned directly by Maveron LLC. Maveron LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein. In addition, Dan Levitan, who is a Director of the issuer, and certain other individuals are managing members of Maveron LLC and may be deemed to share voting and investment power over the shares held of record by Maveron LLC. Each of such individuals disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
  • [F2]Shares are owned directly by Maveron Equity. Maveron General Partner III LLC ("Maveron GP"), which is the general partner of Maveron Equity, has sole voting and investment power over the securities held by Maveron Equity. Maveron GP disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein. In addition, Dan Levitan, who is a Director of the issuer, and certain other individuals are managing members of Maveron GP and may be deemed to share voting and investment power over the shares held of record by Maveron Equity. Each of such individuals disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
  • [F3]Shares acquired by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity.
  • [F4]MEP Associates III, L.P. ("Maveron Associates") made pro rata distributions for no consideration of 116,243 shares of common stock of the issuer to its partners on August 24, 2017.
  • [F5]Shares are owned directly by Maveron Associates. Maveron GP, which is the general partner of Maveron Associates, has sole voting and investment power over the securities held by Maveron Associates. Maveron GP disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein. In addition, Dan Levitan, who is a Director of the issuer, and certain other individuals are managing members of Maveron GP and may be deemed to share voting and investment power over the shares held of record by Maveron Associates. Each of such individuals disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
  • [F6]Maveron III Entrepreneurs Fund, L.P. ("Maveron Entrepreneurs") made pro rata distributions for no consideration of 35,970 shares of common stock of the issuer to its partners on August 24, 2017.
  • [F7]Shares are owned directly by Maveron Entrepreneurs. Maveron GP, which is the general partner of Maveron Entrepreneurs, has sole voting and investment power over the securities held by Maveron Entrepreneurs. Maveron GP disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein. In addition, Dan Levitan, who is a Director of the issuer, and certain other individuals are managing members of Maveron GP and may be deemed to share voting and investment power over the shares held of record by Maveron Entrepreneurs. Each of such individuals disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
  • [F8]Shares acquired by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs.
  • [F9]Maveron GP made pro rata distributions for no consideration of 8,838 shares of common stock of the issuer to its members on August 24, 2017.

Issuer

TRUPANION INC.

CIK 0001371285

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001587645

Filing Metadata

Form type
4
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 7:46 PM ET
Size
26.5 KB